Green Leaf Clinical Trials

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Autism2 trials
• Crohn's disease2 trials
• Bipolar disorder1 trial
• Migraine1 trial
• Schizophrenia1 trial

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Recruiting3 trials
• Completed2 trials

Lead sponsor

• Intra-Cellular Therapies, Inc.2 trials
• Janssen Research & Development, LLC2 trials
• Biohaven Therapeutics Ltd.1 trial

Running trials

• Recruiting

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

  NCT06690398· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Recruiting

  Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  NCT06229210· Phase 3· Intra-Cellular Therapies, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Autism2 recruiting
• Bipolar disorder1 recruiting
• Crohn's disease1 recruiting
• Schizophrenia1 recruiting

Closed trials

• Recruiting

  A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  NCT07196722· Phase 2/3· Janssen Research & Development, LLC· Source

• Completed

  Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine

  NCT06603623· Phase 2· Biohaven Therapeutics Ltd.· Source